I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline.
TVP1022, the S-enantiomer of rasagiline (Azilect®) (N-propargyl-1R-aminoindan), exerts cyto/cardio-protective effects in a variety of experimental cardiac and neuronal models. Previous studies have demonstrated that the protective activity of TVP1022 and other propargyl derivatives involve the activ...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23166584/pdf/?tool=EBI |
id |
doaj-5f118b38e1ff4e3085d81f99839f6506 |
---|---|
record_format |
Article |
spelling |
doaj-5f118b38e1ff4e3085d81f99839f65062021-03-04T00:02:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01711e4789010.1371/journal.pone.0047890I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline.Yaron D BaracOrit Bar-AmEsti LianiTamar AmitLuba FrolovElena OvcharenkoItzchak AngelMoussa B H YoudimOfer BinahTVP1022, the S-enantiomer of rasagiline (Azilect®) (N-propargyl-1R-aminoindan), exerts cyto/cardio-protective effects in a variety of experimental cardiac and neuronal models. Previous studies have demonstrated that the protective activity of TVP1022 and other propargyl derivatives involve the activation of p42/44 mitogen-activated protein kinase (MAPK) signaling pathway. In the current study, we further investigated the molecular mechanism of action and signaling pathways of TVP1022 which may account for the cyto/cardio-protective efficacy of the drug. Using specific receptor binding and enzyme assays, we demonstrated that the imidazoline 1 and 2 binding sites (I(1) & I(2)) are potential targets for TVP1022 (IC(50) =9.5E-08 M and IC(50) =1.4E-07 M, respectively). Western blotting analysis showed that TVP1022 (1-20 µM) dose-dependently increased the immunoreactivity of phosphorylated p42 and p44 MAPK in rat pheochromocytoma PC12 cells and in neonatal rat ventricular myocytes (NRVM). This effect of TVP1022 was significantly attenuated by efaroxan, a selective I(1) imidazoline receptor antagonist. In addition, the cytoprotective effect of TVP1022 demonstrated in NRVM against serum deprivation-induced toxicity was markedly inhibited by efaroxan, thus suggesting the importance of I(1)imidazoline receptor in mediating the cardioprotective activity of the drug. Our findings suggest that the I(1)imidazoline receptor represents a novel site of action for the cyto/cardio-protective efficacy of TVP1022.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23166584/pdf/?tool=EBI |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yaron D Barac Orit Bar-Am Esti Liani Tamar Amit Luba Frolov Elena Ovcharenko Itzchak Angel Moussa B H Youdim Ofer Binah |
spellingShingle |
Yaron D Barac Orit Bar-Am Esti Liani Tamar Amit Luba Frolov Elena Ovcharenko Itzchak Angel Moussa B H Youdim Ofer Binah I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline. PLoS ONE |
author_facet |
Yaron D Barac Orit Bar-Am Esti Liani Tamar Amit Luba Frolov Elena Ovcharenko Itzchak Angel Moussa B H Youdim Ofer Binah |
author_sort |
Yaron D Barac |
title |
I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline. |
title_short |
I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline. |
title_full |
I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline. |
title_fullStr |
I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline. |
title_full_unstemmed |
I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline. |
title_sort |
i1 imidazoline receptor: novel potential cytoprotective target of tvp1022, the s-enantiomer of rasagiline. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2012-01-01 |
description |
TVP1022, the S-enantiomer of rasagiline (Azilect®) (N-propargyl-1R-aminoindan), exerts cyto/cardio-protective effects in a variety of experimental cardiac and neuronal models. Previous studies have demonstrated that the protective activity of TVP1022 and other propargyl derivatives involve the activation of p42/44 mitogen-activated protein kinase (MAPK) signaling pathway. In the current study, we further investigated the molecular mechanism of action and signaling pathways of TVP1022 which may account for the cyto/cardio-protective efficacy of the drug. Using specific receptor binding and enzyme assays, we demonstrated that the imidazoline 1 and 2 binding sites (I(1) & I(2)) are potential targets for TVP1022 (IC(50) =9.5E-08 M and IC(50) =1.4E-07 M, respectively). Western blotting analysis showed that TVP1022 (1-20 µM) dose-dependently increased the immunoreactivity of phosphorylated p42 and p44 MAPK in rat pheochromocytoma PC12 cells and in neonatal rat ventricular myocytes (NRVM). This effect of TVP1022 was significantly attenuated by efaroxan, a selective I(1) imidazoline receptor antagonist. In addition, the cytoprotective effect of TVP1022 demonstrated in NRVM against serum deprivation-induced toxicity was markedly inhibited by efaroxan, thus suggesting the importance of I(1)imidazoline receptor in mediating the cardioprotective activity of the drug. Our findings suggest that the I(1)imidazoline receptor represents a novel site of action for the cyto/cardio-protective efficacy of TVP1022. |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23166584/pdf/?tool=EBI |
work_keys_str_mv |
AT yarondbarac i1imidazolinereceptornovelpotentialcytoprotectivetargetoftvp1022thesenantiomerofrasagiline AT oritbaram i1imidazolinereceptornovelpotentialcytoprotectivetargetoftvp1022thesenantiomerofrasagiline AT estiliani i1imidazolinereceptornovelpotentialcytoprotectivetargetoftvp1022thesenantiomerofrasagiline AT tamaramit i1imidazolinereceptornovelpotentialcytoprotectivetargetoftvp1022thesenantiomerofrasagiline AT lubafrolov i1imidazolinereceptornovelpotentialcytoprotectivetargetoftvp1022thesenantiomerofrasagiline AT elenaovcharenko i1imidazolinereceptornovelpotentialcytoprotectivetargetoftvp1022thesenantiomerofrasagiline AT itzchakangel i1imidazolinereceptornovelpotentialcytoprotectivetargetoftvp1022thesenantiomerofrasagiline AT moussabhyoudim i1imidazolinereceptornovelpotentialcytoprotectivetargetoftvp1022thesenantiomerofrasagiline AT oferbinah i1imidazolinereceptornovelpotentialcytoprotectivetargetoftvp1022thesenantiomerofrasagiline |
_version_ |
1714810800172957696 |